BTAI
BioXcel Therapeutics, Inc.
3.16
USD
This page is just a preview of the data found in TrendSpider’s full version
BioXcel Therapeutics, Inc. stock is down -33.19% since 30 days ago. The next earnings date is Mar 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 5 December’s closed higher than November. In the last 8 Unusual Options Trades, there were 7 CALLs, 1 PUT. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 20 Oct 18:34 | 17 Nov, 2023 | 3.50 | 131 | ||
| 30 Oct 15:47 | 17 Nov, 2023 | 5.00 | 2575 | ||
| 01 Nov 14:01 | 16 Feb, 2024 | 17.50 | 11 | ||
| 01 Nov 18:37 | 17 Nov, 2023 | 4.00 | 736 | ||
| 02 Nov 14:41 | 17 Nov, 2023 | 4.00 | 1189 | ||
| 03 Nov 13:41 | 17 Nov, 2023 | 3.50 | 2400 | ||
| 10 Nov 20:23 | 16 Feb, 2024 | 3.00 | 234 | ||
| 15 Nov 20:02 | 16 Feb, 2024 | 3.00 | 320 |
BioXcel Therapeutics, Inc. uses artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology in the United States. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.
